Abstract:Background: In western patients, the association of Fusobacterium nucleatum (F. nucleatum) with colorectal carcinoma (CRC) has been established, but the underlying mechanism remains unclear. There is no report about F. nucleatum infection status and its potential role in CRC patients in China. This study aimed to evaluate infection status and infection load of F. nucleatum and its correlation with clinicopathological features and prognosis of CRC patients in China.Methods: Fresh tumor and adjacent normal mucosa tissues were obtained at surgery from 152 CRC patients, and then DNA was assayed for infection of F. nucleatum by quantitative PCR. Then the association of infection with clinicopathological features and prognosis was evaluated. In addition, MMP9, MMP11, CD45RO and FOXP3 expression levels was assessed by immunohistochemistry to explore the potential role of F. nucleatum.Results: The infection rate of F. nucleatum in CRC tissues was significantly higher than that in adjacent normal tissues (77.6% vs. 57.2%, P<0.001), and median F. nucleatum copy number was also significantly higher in CRC tissues than in adjacent normal tissues (87 vs. 37, P<0.001). F. nucleatum infection of tumor tissues was related with poorer tumor differentiation (P<0.001), deeper tumor invasion (P<0.001), lymph node metastasis (P=0.01), distant metastasis (P=0.001) and advanced TNM stage (P=0.034). Specimens with higher infection load contained fewer CD45RO(+) T lymphocytes and more FOXP3(+) regulatory T lymphocytes than those with lower infection load. And high-copy group had a poorer postoperative survival than the low-copy group (P=0.027). In the subset of CRC patients with F. nucleatum infection, tumor stage and F. nucleatum infection were independent prognostic factors. Advanced tumor stage and high-load infection were correlated poorer prognosis (P=0.023 and 0.032, respectively).Conclusions: Infection rate and load of F. nucleatum are higher in carcinoma tissues than in adjacent normal tissues from CRC patients in Chian. F. nucleatum infection was correlated with tumor metastasis and overall postoperative survival of colorectal cancer patients, so it can help to improve prevention, diagnosis and treatment of CRC in China.

Association of Fusobacterium nucleatum infection with the clinicopathological characteristics in colorectal cancer patients

Fusobacterium Nucleatum Subspecies Animalis Influences Proinflammatory Cytokine Expression and Monocyte Activation in Human Colorectal Tumors.

Fusobacterium nucleatum, a key pathogenic factor and microbial biomarker for colorectal cancer

Fusobacterium nucleatum and colorectal cancer: From phenomenon to mechanism

Fusobacterium nucleatum Acts as a Pro-carcinogenic Bacterium in Colorectal Cancer: From Association to Causality

Association between Fusobacterium nucleatum and colorectal cancer: Progress and future directions

EXPRESS: The role of Fusobacterium nucleatum in the pathogenesis of colon cancer

Fusobacterium and Colorectal Cancer

Dysbiosis Signature of Fecal Microbiota in Colorectal Cancer Patients

The role of Fusobacterium nucleatum in colorectal cancer: from carcinogenesis to clinical management

Fusobacterium nucleatum and colorectal cancer: A review

<i>Fusobacterium nucleatum</i> promotes colorectal cancer metastasis by modulating <i>KRT7-AS</i>/KRT7

Fusobacterium Nucleatum Infection is Correlated with Tumor Metastasis and Postoperative Survival of Colorectal Cancer Patients in China

Fusobacterium nucleatum promotes colorectal cancer metastasis by modulating KRT7-AS /KRT7.

The Role of Fusobacterium nucleatum in Colorectal Cancer Cell Proliferation and Migration

Fusobacterium nucleatum induces a tumor microenvironment with diminished adaptive immunity against colorectal cancers

Southern Chinese Populations Harbour Non-Nucleatum Fusobacteria Possessing Homologues of the Colorectal Cancer-Associated FadA Virulence Factor.

Fusobacterium nucleatum - symbiont, opportunist and oncobacterium

Fusobacterium Nucleatum: a New Player in Regulation of Cancer Development and Therapeutic Response.

Network Analysis of Gut Microbiota Including Fusobacterium and Oral Origin Bacteria and Their Distribution on Tumor Surface, Normal Mucosa, and in Feces in Patients with Colorectal Cancer

Microbiota Profile and Impact of Fusobacterium nucleatum in Colorectal Cancer Patients of Barretos Cancer Hospital